Sanofi terminates deal to exclusively license Maze Therapeutics Pompe disease drug Ruchika Sharma12 Dec 2023 2:30 PM ISTWashington: Sanofi has said it was terminating a deal to exclusively license a drug that Maze Therapeutics is developing to treat Pompe disease...
Torrent Pharma gets 5 USFDA observations for Gujarat facility Ruchika Sharma12 Dec 2023 1:06 PM ISTAhmedabad: Torrent Pharma has announced that the United States Food and Drug Administration (USFDA) has concluded the inspection with 5 procedural...
Bristol Myers Squibb, SystImmune collaborate for development, commercialization of BL-B01D1 Ruchika Sharma12 Dec 2023 12:30 PM ISTPrinceton: SystImmune, a clinical-stage biopharmaceutical company, and Bristol Myers Squibb have announced an exclusive license and collaboration...
Pfizer Marstacimab regulatory submissions for treatment of Hemophilia A and B accepted by USFDA, EMA Ruchika Sharma12 Dec 2023 11:28 AM ISTThe submissions for marstacimab are based on efficacy and safety data from the Phase 3 BASIS trial.
Cipla US arm recalls Vigabatrin for Oral Solution, USP 500mg over pouch leakage issues Ruchika Sharma11 Dec 2023 3:00 PM ISTCipla has not received any reports of adverse events related to this recall.
Sarclisa plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone: Sanofi Ruchika Sharma11 Dec 2023 2:30 PM ISTParis: Sanofi has announced that the Phase 3 trial investigating Sarclisa (isatuximab) in combination with carfilzomib, lenalidomide and...
Zydus, Daewoong Pharma collaborate to co-develop, commercialise Leuprolide Long-Acting Injectable in US Ruchika Sharma11 Dec 2023 12:30 PM ISTLeuprolide acetate for depot suspension is a gonadotropin-releasing hormone (GnRH) agonist, a long-acting injectable product in a kit with a prefilled...
Intas Pharma gets USFDA warning letter due to manufacturing lapses at Ahmedabad plant Ruchika Sharma11 Dec 2023 11:30 AM IST"Repeated failures demonstrate that executive management oversight and control over the manufacture of drugs is inadequate," USFDA said.
Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
Ozempic side effects lawsuit can move forward Ruchika Sharma10 Dec 2023 12:30 PM ISTA Louisiana federal judge on Friday largely rejected Novo Nordisk’s bid to dismiss one of the earliest lawsuits brought against the pharmaceutical...
Sanofi multiple myeloma drug Sarclisa phase 3 trial meets primary endpoint of progression-free survival Ruchika Sharma10 Dec 2023 11:30 AM ISTParis: Sanofi has announced that the Phase 3 IMROZ trial evaluating the investigational use of Sarclisa (isatuximab) in combination with...
Bayer, Salus Optima collaborate on AI-Enabled Healthy Aging Journey Ruchika Sharma10 Dec 2023 10:00 AM ISTLondon: Salus Optima, a provider of AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a...
